Expectations trend
FY2028 · fiscal year ending 2028-02-01 · fmp
NYSEConsumer DiscretionaryApparel - ManufacturersSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
12.50 → 12.50 EPS · FY ending Feb 1, 2028 · 6 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 6 to 6; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for PVH yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Maintain strong cash flow from operations above $580M | Cash flow from operations has improved strongly to over $580M. | Intact | Cash flow from operations falls below $400M over next 4 quarters | Cash from operations: $382.9M FY2026-Q2; GAAP. Published target: Cash from operations >= $580M. Target period is not explicitly aligned with this observation. Sep 2, 2026382,900,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2028 · fiscal year ending 2028-02-01 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
PVH is a branded-apparel business with a recovery-dependent long-term thesis, rather than a steady compounder at this point. The thesis is still under watch because recent financial performance trails its industry cohort, despite momentum improving from a deeply negative level.
The valuation evidence describes PVH as cheap versus peers, but also shows a negative expectations gap, meaning the market’s assumptions appear more demanding than the model’s view. Overall, the priced-in assessment is tagged justified, with low fragility; the evidence does not point to a clearly stretched setup.
Near term, results remain weak, although the company reported an earnings beat and its momentum measure improved. Direct-to-consumer revenue was approximately flat in the latest quarter, while digital commerce grew; reported margin strength included a substantial tariff-refund benefit, and the full-year margin outlook remained lower. Restructuring is underway, but the supplied evidence does not yet show realized cost or productivity gains.
A favorable shift would require PVH to reverse its lowered guidance and raise it next quarter. The multi-year case also depends on sustained delivery in direct-to-consumer growth, recurring margin improvement, and measurable benefits from simplifying operations. Sector bellwethers’ results and guidance could either support or weaken the near-term backdrop.
Over the next 1 to 3 years, PVH’s thesis depends on turning improving momentum into durable operating progress; current evidence shows some delivery but leaves important execution questions open. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A primary condition in PVH Corp.'s published investment case. The stated target is EPS $11.8 to $12.1. |
| Intact |
| EPS falls below $11.0 in FY26 |
Diluted EPS: $-2.23 per share FY2027-Q2; GAAP. Published target: EPS $11.8 to $12.1. Annual target cannot be compared with a quarterly or TTM observation. Sep 2, 2026-2.23 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Maintain operating margin near 8.8% in FY26 | A primary condition in PVH Corp.'s published investment case. The stated target is 8.8% operating margin. | Intact | Operating margin falls below 7.5% in FY26 | Operating margin: -9.1% FY2027-Q2; GAAP. Published target: 8.8% operating margin. Annual target cannot be compared with a quarterly or TTM observation. Sep 2, 2026-9.103481 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stabilize revenue growth near 0.5% in next 12 months | A supporting condition in PVH Corp.'s published investment case. The stated target is >=0% revenue growth. | Under Pressure | Revenue growth falls below -2% next 12 months | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$12.46 → $12.50 · observed estimates
$9.05B → $9.05B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $12.46 | $9,049,393,589 | 6 / 9 |
| 2026-07-25 | $12.46 | $9,049,393,589 | 6 / 9 |
| 2026-07-26 | $12.46 | $9,049,393,589 | 6 / 9 |
| 2026-07-27 | $12.46 | $9,049,393,589 | 6 / 9 |
| 2026-07-28 | $12.46 | $9,049,393,589 | 6 / 9 |
| 2026-07-29 | $12.46 | $9,049,393,589 | 6 / 9 |
| 2026-07-30 | $12.46 | $9,049,393,589 | 6 / 9 |
| 2026-07-31 | $12.46 | $9,049,393,589 | 6 / 9 |
| 2026-08-01 | $12.46 | $9,049,393,589 | 6 / 9 |
| 2026-08-02 | $12.46 | $9,049,393,589 | 6 / 9 |
| 2026-08-03 | $12.46 | $9,049,393,589 | 6 / 9 |
| 2026-08-04 | $12.46 | $9,049,393,589 | 6 / 9 |
| 2026-08-05 | $12.46 | $9,049,393,589 | 6 / 9 |
| 2026-08-06 | $12.46 | $9,049,393,589 | 6 / 9 |
| 2026-08-07 | $12.46 | $9,049,393,589 | 6 / 9 |
| 2026-08-08 | $12.46 | $9,049,393,589 | 6 / 9 |
| 2026-08-09 | $12.46 | $9,049,393,589 | 6 / 9 |
| 2026-08-10 | $12.46 | $9,049,393,589 | 6 / 9 |
| 2026-08-12 | $12.46 | $9,049,393,589 | 6 / 9 |
| 2026-08-13 | $12.46 | $9,049,393,589 | 6 / 9 |
| 2026-08-14 | $12.46 | $9,049,393,589 | 6 / 9 |
| 2026-08-15 | $12.46 | $9,049,393,589 | 6 / 9 |
| 2026-08-16 | $12.46 | $9,049,393,589 | 6 / 9 |
| 2026-08-17 | $12.46 | $9,049,393,589 | 6 / 9 |
| 2026-08-18 | $12.46 | $9,049,393,589 | 6 / 9 |
| 2026-08-19 | $12.46 | $9,049,393,589 | 6 / 9 |
| 2026-08-20 | $12.60 | $9,043,747,727 | 6 / 9 |
| 2026-08-21 | $12.60 | $9,043,747,727 | 6 / 9 |
| 2026-08-22 | $12.60 | $9,045,863,530 | 6 / 9 |
| 2026-08-23 | $12.60 | $9,045,863,530 | 6 / 9 |
| 2026-08-24 | $12.60 | $9,045,863,530 | 6 / 9 |
| 2026-08-25 | $12.60 | $9,045,863,530 | 6 / 9 |
| 2026-08-26 | $12.60 | $9,045,863,530 | 6 / 9 |
| 2026-08-27 | $12.60 | $9,045,863,530 | 6 / 9 |
| 2026-08-28 | $12.60 | $9,045,863,530 | 6 / 9 |
| 2026-08-29 | $12.60 | $9,045,863,530 | 6 / 9 |
| 2026-08-30 | $12.60 | $9,045,863,530 | 6 / 9 |
| 2026-08-31 | $12.60 | $9,045,863,530 | 6 / 9 |
| 2026-09-01 | $12.60 | $9,045,863,530 | 6 / 9 |
| 2026-09-02 | $12.60 | $9,045,863,530 | 6 / 9 |
| 2026-09-03 | $12.56 | $9,033,921,864 | 6 / 9 |
| 2026-09-04 | $12.53 | $9,043,528,467 | 6 / 9 |
| 2026-09-05 | $12.50 | $9,050,863,449 | 6 / 9 |
| 2026-09-06 | $12.50 | $9,050,863,449 | 6 / 9 |
| 2026-09-07 | $12.50 | $9,050,863,449 | 6 / 9 |
| 2026-09-08 | $12.50 | $9,050,863,449 | 6 / 9 |
| 2026-09-09 | $12.50 | $9,050,863,449 | 6 / 9 |
| 2026-09-10 | $12.50 | $9,050,863,449 | 6 / 9 |
| 2026-09-11 | $12.50 | $9,050,863,449 | 6 / 9 |
| 2026-09-12 | $12.50 | $9,050,863,449 | 6 / 9 |
| 2026-09-13 | $12.50 | $9,050,863,449 | 6 / 9 |
| 2026-09-14 | $12.50 | $9,050,863,449 | 6 / 9 |
| 2026-09-15 | $12.50 | $9,050,863,449 | 6 / 9 |
| 2026-09-16 | $12.50 | $9,050,863,449 | 6 / 9 |
| 2026-09-17 | $12.50 | $9,050,863,449 | 6 / 9 |
| 2026-09-18 | $12.50 | $9,050,863,449 | 6 / 9 |
| 2026-09-19 | $12.50 | $9,050,863,449 | 6 / 9 |
| 2026-09-20 | $12.50 | $9,050,863,449 | 6 / 9 |
| 2026-09-21 | $12.50 | $9,050,863,449 | 6 / 9 |
| 2026-09-22 | $12.50 | $9,050,863,449 | 6 / 9 |
| 2026-09-23 | $12.50 | $9,050,863,449 | 6 / 9 |
| 2026-09-24 | $12.50 | $9,050,863,449 | 6 / 9 |
| 2026-09-25 | $12.50 | $9,050,863,449 | 6 / 9 |
| 2026-09-26 | $12.50 | $9,050,863,449 | 6 / 9 |
| 2026-09-27 | $12.50 | $9,050,863,449 | 6 / 9 |
| 2026-09-28 | $12.50 | $9,050,863,449 | 6 / 9 |
| 2026-09-29 | $12.50 | $9,050,863,449 | 6 / 9 |
| 2026-09-30 | $12.50 | $9,050,863,449 | 6 / 9 |
| 2026-10-01 | $12.50 | $9,050,863,449 | 6 / 9 |
| 2026-10-02 | $12.50 | $9,050,863,449 | 6 / 9 |
| 2026-10-03 | $12.50 | $9,050,863,449 | 6 / 9 |
| 2026-10-04 | $12.50 | $9,050,863,449 | 6 / 9 |
| 2026-10-05 | $12.50 | $9,050,863,449 | 6 / 9 |
| 2026-10-06 | $12.50 | $9,050,863,449 | 6 / 9 |
| 2026-10-07 | $12.50 | $9,050,863,449 | 6 / 9 |
| 2026-10-08 | $12.50 | $9,050,866,882 | 6 / 9 |
| 2026-10-09 | $12.50 | $9,050,866,882 | 6 / 9 |
| 2026-10-10 | $12.46 | $9,050,866,882 | 6 / 9 |
| 2026-10-11 | $12.46 | $9,050,866,882 | 6 / 9 |
| 2026-10-12 | $12.46 | $9,050,866,882 | 6 / 9 |
| 2026-10-13 | $12.46 | $9,050,866,882 | 6 / 9 |
| 2026-10-14 | $12.46 | $9,050,866,882 | 6 / 9 |
| 2026-10-15 | $12.46 | $9,043,450,215 | 6 / 9 |
| 2026-10-16 | $12.46 | $9,043,450,215 | 6 / 9 |
| 2026-10-17 | $12.46 | $9,043,450,215 | 6 / 9 |
| 2026-10-18 | $12.46 | $9,043,450,215 | 6 / 9 |
| 2026-10-19 | $12.46 | $9,043,450,215 | 6 / 9 |
| 2026-10-20 | $12.46 | $9,043,450,215 | 6 / 9 |
| 2026-10-21 | $12.52 | $9,057,246,726 | 6 / 9 |
| 2026-10-22 | $12.50 | $9,054,883,090 | 6 / 9 |
| 2026-10-23 | $12.50 | $9,054,883,090 | 6 / 9 |
| 2026-10-24 | $12.50 | $9,054,883,090 | 6 / 9 |
| 2026-10-25 | $12.50 | $9,054,883,090 | 6 / 9 |
| 2026-10-26 | $12.50 | $9,054,883,090 | 6 / 9 |
| 2026-10-27 | $12.50 | $9,054,883,090 | 6 / 9 |
| 2026-10-28 | $12.50 | $9,054,883,090 | 6 / 9 |
| 2026-10-29 | $12.50 | $9,054,883,090 | 6 / 9 |
| 2026-10-30 | $12.50 | $9,054,883,090 | 6 / 9 |
| 2026-10-31 | $12.50 | $9,054,883,090 | 6 / 9 |
| 2026-11-01 | $12.50 | $9,054,883,090 | 6 / 9 |
| 2026-11-02 | $12.50 | $9,054,883,090 | 6 / 9 |
| 2026-11-03 | $12.50 | $9,054,883,090 | 6 / 9 |
| 2026-11-04 | $12.50 | $9,054,883,090 | 6 / 9 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 6 Buy / Strong Buy · 4 Hold · 2 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 1 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Dec 2, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.